Publications

Export 5374 results:
Sort by: Author [ Title  (Asc)] Type Year
A B C D E F G H I J K L M N O P Q [R] S T U V W X Y Z   [Show ALL]
R
Moharram, M. A., and A. A. Kishk, "The random auxiliary sources method: A simple, fast, and efficient electromagnetic scattering computations approach", Computational Electromagnetics (ICCEM), 2015 IEEE International Conference on: IEEE, pp. 5-7, 2015. Abstract
n/a
Metwalli, S. M., "Random Equivalence in Engineering Mechanics", Recent Advances in Engineering Mechanics and Their Impact on Civil Engineering Practice: ASCE, pp. 275–278, 1983. Abstract
n/a
Azar, A. T., H. I. Elshazly, A. E. Hassanien, and A. M. Elkorany, "Random Forest Classifier for Lymph Diseases", Computer Methods and Programs in Biomedicine , Elsevier 2013 , vol. 113, issue 2, pp. 465-473 , 2014. Website
Azar, A. T., H. I. Elshazly, A. E. Hassanien, and A. M. Elkorany, "A random forest classifier for lymph diseases", Computer methods and programs in biomedicine, vol. 113, no. 2: Elsevier, pp. 465–473, 2014. Abstract
n/a
Azar, A. T., H. I. Elshazly, A. E. Hassanien, and A. M. Elkorany, "A random forest classifier for lymph diseases", Computer methods and programs in biomedicine, vol. 113, no. 2: Elsevier, pp. 465–473, 2014. Abstract
n/a
Esraa Elhariri, N. El-Bendary, A. E. Hassanien, A. Badr, Ahmed M. M. Hussein, and V. Snasel, "Random forests based classification for crops ripeness stage", The 5th International Conference on Innovations in Bio-Inspired Computing and Applications (Springer) IBICA2014, Ostrava, Czech Republic., 22-24 June, 2014. ibica2014p25.pdf
E.Elharir, N.El-Bendary, A.Hassanien, A.Badr, A. M. M. Hussein, and V.Snasel, "Random Forests Based Classification for Crops Ripeness Stages", Proceedings of the Fifth International Conference on Innovations in Bio-Inspired Computing and Applications IBICA 2014, vol. 303: Springer International Publishing, pp. 205–215, 2014. Abstract

n/a

Esraa Elhariri, N. El-Bendary, A. E. Hassanien, A. Badr, A. M. M. Hussein, and Václav Snášel, "Random forests based classification for crops ripeness stages", Proceedings of the Fifth International Conference on Innovations in Bio-Inspired Computing and Applications IBICA 2014: Springer International Publishing, pp. 205–215, 2014. Abstract
n/a
Zidan, A. M., A. G. Radwan, and K. N. Salama, "Random number generation based on digital differential chaos", Circuits and Systems (MWSCAS), 2011 IEEE 54th International Midwest Symposium on: IEEE, pp. 1–4, 2011. Abstract
n/a
Zidan, A. M., A. G. Radwan, and K. N. Salama, "Random number generation based on digital differential chaos", Circuits and Systems (MWSCAS), 2011 IEEE 54th International Midwest Symposium on: IEEE, pp. 1–4, 2011. Abstract
n/a
Metwalli, S. M., and S. M. Megahed, "Random response of nonlinear systems by deterministic equivalence", Developments in mechanics., vol. 12, pp. 19–22, 1983. Abstract
n/a
Metwalli, S. M., and R. W. Mayne, "Random to deterministic transform", Journal of Sound and Vibration, vol. 79, no. 2: Elsevier, pp. 197–204, 1981. Abstract
n/a
Al-Sawaf, A., A. El-Mazny, and A. Shohayeb, "A randomised controlled trial of sublingual misoprostol and intramuscular oxytocin for prevention of postpartum haemorrhage.", Journal of Obstetrics & Gynaecology, vol. 33, issue 3, pp. 277-279, 2013. AbstractWebsite

This study aims to evaluate the efficacy and side-effects of 200 μg sublingual misoprostol vs 5 IU i.m. oxytocin, administered immediately following cord clamping in normal non-augmented vaginal delivery, in prevention of postpartum haemorrhage (PPH). A total of 104 women were randomised into three groups: misoprostol group (28 patients); oxytocin group (37 patients) and control group (39 patients). Misoprostol and oxytocin significantly minimised the blood loss during the third stage of labour and reduced the need for additional treatments for PPH as compared with the control group. Oxytocin was more effective than misoprostol in minimising blood loss and the need for additional uterotonic treatments. However, a significant decrease in systolic and diastolic blood pressure, associated with tachycardia was observed in the oxytocin group. In conclusion, sublingual misoprostol appears to be less effective than i.m. oxytocin in the prevention of PPH; however, it has the potential advantages of being easily used, cost-effective and stable at room temperature. Therefore, sublingual misoprostol is still a feasible drug for routine management of third stage, especially in areas with limited medical facilities.

Ramanan, A. V., A. D. Dick, D. Benton, S. Compeyrot-Lacassagne, D. Dawoud, B. Hardwick, H. Hickey, D. Hughes, A. Jones, P. Woo, et al., "A randomised controlled trial of the clinical effectiveness, safety and cost-effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitis (SYCAMORE Trial).", Trials, vol. 15, pp. 14, 2014. Abstract

BACKGROUND: Juvenile idiopathic arthritis (JIA) is the most common rheumatic disease in children. Children with JIA are at risk of inflammation of the uvea in the eye (uveitis). Overall, 20% to 25% of paediatric uveitis is associated with JIA. Major risk factors for development of uveitis in JIA are oligoarticular pattern of arthritis, an age at onset of arthritis of less than seven years of age, and antinuclear antibody positivity. In the initial stages of mild to moderate inflammation the uveitis is asymptomatic. This has led to current practice of screening all children with JIA for uveitis. Approximately 12% to 38% of patients with JIA develop uveitis in seven years following onset of arthritis. In 30% to 50% of children with JIA-associated uveitis structural complications are present at diagnosis. Furthermore about 50% to 75% of those with severe uveitis will eventually develop visual impairment secondary to ocular complications such as cataract and glaucoma. Defining the severity of inflammation and structural complications in uveitis patients is now possible following Standardised Uveitis Nomenclature (SUN) guidelines, and modified to incorporate the consensus of end point and outcome criteria into the design of randomised trials. Despite current screening and therapeutic options (pre-biologics) 10% to 15% of children with JIA-associated uveitis may develop bilateral visual impairment and certified legally blind. To date, there remains no controlled trial evidence of benefits of biologic therapy.

METHODS/DESIGN: This study will randomise 154 patients aged 2 to 18 years with active JIA-associated uveitis (despite methotrexate (MTX) treatment for at least 12 weeks). All participants will be treated for 18 months, with follow up of 3 years from randomisation (continuing on MTX throughout). All participants will receive a stable dose of MTX and in addition either adalimumab (20 mg/0.8 ml for patients<30 kg or 40 mg/0.8 ml for patients weighing 30 kg or more, subcutaneous (s/c) injection every 2 weeks based on body weight), or placebo (0.8 ml as appropriate according to body weight) s/c injection every 2 weeks.

DISCUSSION: This is the first randomised controlled trial that will assess the clinical effectiveness, safety and cost effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitis.

TRIAL REGISTRATION: ISRCTN10065623.

IM, T., N. M. Kamal, and A. M. A. Alghamdi HA, Alharthi AA, "A randomized clinical trial comparing 3 different replacement regimens of vitamin D in clinically asymptomatic pediatrics and adolescents with vitamin D insufficiency.", Italian J Pediatrics, vol. 2, issue 1, pp. 106, 2016. vit_d.pdf
Zaghloul, M. S., A. Abdallah, H. William, H. M. Khaled, J. P. Christodouleas, and A. Smith, "A randomized clinical trial comparing adjuvant radiation vs chemo-RT vs chemotherapy alone after radical cystectomy for locally advanced bladder cancer", ASCO, united states, 7-9 jan, 2016. abstract_gu-asco.docx
Abdel Magid, A. M., M. M. Abbassi, E. E. M. Iskander, O. Mohamady, and S. F. Farid, "Randomized comparative efficacy and safety study of intermittent simvastatin versus fenofibrate in hemodialysis.", Journal of comparative effectiveness research, vol. 6, issue 5, pp. 413-424, 2017 Jul. Abstract

AIM: Compare the safety and efficacy of intermittent fenofibrate versus simvastatin in chronic hemodialysis patients.

PATIENTS & METHODS: Sixty patients received either fenofibrate 100 mg or simvastatin 20 mg after their dialysis session (parallel study). The safety and efficacy of drugs on lipid profile, oxidized low-density lipoprotein (Ox-LDL), glutathione peroxidase and C-reactive protein were compared before and after 16-week treatment.

RESULTS: After treatment, significant increase in glutathione peroxidase, significant decrease in total cholesterol, triglycerides, low density lipoprotein (LDL) and ox-LDL (p < 0.05) and no significant changes in C-reactive protein (p > 0.05) were observed in both groups. Both drugs were well tolerated with no serious side effects reported by the patients.

CONCLUSION: Both drugs have comparable efficacy and safety when used as intermittent low dose regimen in hemodialysis. Larger studies with longer follow-up periods are needed to confirm our new findings.

Abdel Magid, A. M., M. M. Abbassi, E. E. M. Iskander, O. Mohamady, and S. F. Farid, "Randomized comparative efficacy and safety study of intermittent simvastatin versus fenofibrate in hemodialysis.", Journal of comparative effectiveness research, vol. 6, issue 5, pp. 413-424, 2017. Abstract

AIM: Compare the safety and efficacy of intermittent fenofibrate versus simvastatin in chronic hemodialysis patients.

PATIENTS & METHODS: Sixty patients received either fenofibrate 100 mg or simvastatin 20 mg after their dialysis session (parallel study). The safety and efficacy of drugs on lipid profile, oxidized low-density lipoprotein (Ox-LDL), glutathione peroxidase and C-reactive protein were compared before and after 16-week treatment.

RESULTS: After treatment, significant increase in glutathione peroxidase, significant decrease in total cholesterol, triglycerides, low density lipoprotein (LDL) and ox-LDL (p < 0.05) and no significant changes in C-reactive protein (p > 0.05) were observed in both groups. Both drugs were well tolerated with no serious side effects reported by the patients.

CONCLUSION: Both drugs have comparable efficacy and safety when used as intermittent low dose regimen in hemodialysis. Larger studies with longer follow-up periods are needed to confirm our new findings.

REDA, D. R. W. A. L. E. E. D., "Randomized Comparative Study between Mathieu Flip-Flap and Snodgrass Techniques for Repair of Distal Hypospadias", Egyptian Journal of Plastic and Reconstructive Surgery., vol. 31, issue 2, pp. JULY, 2007.
Ammar, T., "A randomized comparison of supervised clinical exercise versus a home exercise program in patients with chronic low back pain", Physical Therapy and Rehabilitation, vol. 4, issue 7, pp. 4-7, 2017.
Maged, A. M., E. H. Sorour, M. M. ElSadek, S. M. Hassan, and A. Y. Shoab, "A randomized controlled study of the effect of hyoscine butylbromide on duration of labor in primigravida women with prolonged labor", Archives of Gynecology and Obstetrics, vol. 304, pp. 1513–1518, 2021. hyoscine.pdf
Tourism